Stay updated on Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page.
Latest updates to the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check16 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference4%
- Check23 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check80 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
Stay in the know with updates to Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page.